Form 8-K - Current report:
SEC Accession No. 0001683168-21-002904
Filing Date
2021-07-09
Accepted
2021-07-09 16:31:44
Documents
3
Period of Report
2021-07-05
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k-item0401.htm 8-K 21554
2 LETTER FROM ACCOUNTANTS sonoma_8k-ex1601.htm EX-16.1 2861
3 GRAPHIC image_001.jpg GRAPHIC 3845
  Complete submission text file 0001683168-21-002904.txt   31067
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 211083166
SIC: 2834 Pharmaceutical Preparations